Mortality and Adverse Events of Special Interest in Adult Patients with Systemic Lupus Erythematosus Receiving Intravenous Belimumab: A Post Hoc Descriptive Summary of Serious Psychiatric Events

dc.creatorSheikh, Saira
dc.creatorDe Toledo, Ricardo Acayaba
dc.creatorGeraldino Pardilla, Laura
dc.creatorHarris, Julia
dc.creatorKurrasch, Regina
dc.creatorLiu, Andrew
dc.creatorMaksimowicz-McKinnon, Kathleen
dc.creatorQuasny, Holly
dc.creatorRoth, David
dc.creatorSoto Sáez, Lilian
dc.creatorPunwaney, Rajesh
dc.date.accessioned2021-06-24T22:11:16Z
dc.date.available2021-06-24T22:11:16Z
dc.date.created2021-06-24T22:11:16Z
dc.date.issued2020
dc.identifierArthritis & Rheumatology Volumen: 72 Suplemento: 10 Oct 2020
dc.identifier2326-5191
dc.identifierhttps://repositorio.uchile.cl/handle/2250/180257
dc.languageen
dc.publisherWiley
dc.sourceArthritis & Rheumatology
dc.subjectLupus erythematosus
dc.titleMortality and Adverse Events of Special Interest in Adult Patients with Systemic Lupus Erythematosus Receiving Intravenous Belimumab: A Post Hoc Descriptive Summary of Serious Psychiatric Events
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución